Burning Rock Biotech (BNR) Notes Payables (2020 - 2025)
Historic Notes Payables for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $28000.0.
- Burning Rock Biotech's Notes Payables fell 6543.21% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year decrease of 6543.21%. This contributed to the annual value of $81000.0 for FY2024, which is 5207.1% down from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Notes Payables is $28000.0, which was down 6543.21% from $83000.0 recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Notes Payables peaked at $972000.0 during Q4 2021, and registered a low of $28000.0 during Q3 2025.
- Moreover, its 5-year median value for Notes Payables was $162000.0 (2021), whereas its average is $191421.1.
- In the last 5 years, Burning Rock Biotech's Notes Payables plummeted by 9315.88% in 2021 and then surged by 18771.93% in 2023.
- Over the past 5 years, Burning Rock Biotech's Notes Payables (Quarter) stood at $972000.0 in 2021, then tumbled by 73.15% to $261000.0 in 2022, then crashed by 35.25% to $169000.0 in 2023, then plummeted by 52.07% to $81000.0 in 2024, then plummeted by 65.43% to $28000.0 in 2025.
- Its Notes Payables was $28000.0 in Q3 2025, compared to $83000.0 in Q2 2025 and $82000.0 in Q1 2025.